Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950129-04-002008
Filing Date
2004-04-09
Accepted
2004-04-09 14:07:41
Documents
9
Period of Report
2004-05-13
Effectiveness Date
2004-04-09

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT v97283def14a.htm DEF 14A 342481
3 GRAPHIC v97283v9728305.gif GRAPHIC 4072
4 GRAPHIC v97283v9728300.gif GRAPHIC 2070
5 GRAPHIC v97283v9728306.gif GRAPHIC 5188
6 GRAPHIC v97283v9728301.gif GRAPHIC 7296
7 GRAPHIC v97283v9728303.gif GRAPHIC 3360
8 GRAPHIC v97283v9728304.gif GRAPHIC 1628
9 GRAPHIC v97283v9728307.gif GRAPHIC 1720
10 GRAPHIC v97283v9728308.gif GRAPHIC 2512
  Complete submission text file 0000950129-04-002008.txt   372905
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-12477 | Film No.: 04726826
SIC: 2836 Biological Products, (No Diagnostic Substances)